4 employees
Oncolinx is developing antibody-drug conjugates.
2013
$1M
from 2 investors over 2 rounds
Oncolinx raised $1M on October 27, 2016
Investors: 43North
Oncolinx raised $57K on May 1, 2016
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)